NCT03810495View on ClinicalTrials.gov

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

March 18, 2021

Study Completion Date

March 22, 2021

Conditions
Opioid Use Disorder
Interventions
DRUG

naltrexone implant

1.8 g implant containing 60% naltrexone

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

Clinilabs, Inc.
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

New York State Psychiatric Institute

OTHER

collaborator

Columbia University

OTHER

collaborator

Clinilabs, Inc.

OTHER

lead

Go Medical Industries Pty Ltd

INDUSTRY

NCT03810495 - The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter